247 related articles for article (PubMed ID: 16387575)
1. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
Kostis JB; Jackson G; Rosen R; Barrett-Connor E; Billups K; Burnett AL; Carson C; Cheitlin M; Debusk R; Fonseca V; Ganz P; Goldstein I; Guay A; Hatzichristou D; Hollander JE; Hutter A; Katz S; Kloner RA; Mittleman M; Montorsi F; Montorsi P; Nehra A; Sadovsky R; Shabsigh R
Am J Cardiol; 2005 Dec; 96(12B):85M-93M. PubMed ID: 16387575
[TBL] [Abstract][Full Text] [Related]
2. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
Kostis JB; Jackson G; Rosen R; Barrett-Connor E; Billups K; Burnett AL; Carson C; Cheitlin M; Debusk R; Fonseca V; Ganz P; Goldstein I; Guay A; Hatzichristou D; Hollander JE; Hutter A; Katz S; Kloner RA; Mittleman M; Montorsi F; Montorsi P; Nehra A; Sadovsky R; Shabsigh R
Am J Cardiol; 2005 Jul; 96(2):313-21. PubMed ID: 16018863
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle management of erectile dysfunction: the role of cardiovascular and concomitant risk factors.
Rosen RC; Friedman M; Kostis JB
Am J Cardiol; 2005 Dec; 96(12B):76M-79M. PubMed ID: 16387573
[TBL] [Abstract][Full Text] [Related]
4. [Erectile dysfunction and cardiovascular disease in clinical practice].
Roumeguère T; Wespes E
Rev Med Brux; 2007 Sep; 28(4):360-6. PubMed ID: 17958034
[TBL] [Abstract][Full Text] [Related]
5. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.
Jackson G; Rosen RC; Kloner RA; Kostis JB
J Sex Med; 2006 Jan; 3(1):28-36; discussion 36. PubMed ID: 16409215
[TBL] [Abstract][Full Text] [Related]
6. [The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].
Bryniarski L; Rzepecki M; Klocek M; Wyczołkowski M
Przegl Lek; 2009; 66(4):192-7. PubMed ID: 19708509
[TBL] [Abstract][Full Text] [Related]
7. Prevention and management of cardiovascular disease and erectile dysfunction: toward a common patient-centered, care model.
Hatzichristou D; Tsimtsiou Z
Am J Cardiol; 2005 Dec; 96(12B):80M-84M. PubMed ID: 16387574
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.
Jackson G; Montorsi P; Cheitlin MD
Urology; 2006 Sep; 68(3 Suppl):47-60. PubMed ID: 17011375
[TBL] [Abstract][Full Text] [Related]
9. Erectile dysfunction is a signal of risk for cardiovascular disease: a primary care view.
Sadovsky R; Miner M
Prim Care; 2005 Dec; 32(4):977-93, vii. PubMed ID: 16326223
[TBL] [Abstract][Full Text] [Related]
10. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease.
Kapur V; Chien CV; Fuess JE; Schwarz ER
Rev Cardiovasc Med; 2008; 9(3):187-95. PubMed ID: 18953278
[TBL] [Abstract][Full Text] [Related]
11. How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors.
Schwartz BG; Kloner RA
Int J Impot Res; 2009; 21(6):327-35. PubMed ID: 19693019
[TBL] [Abstract][Full Text] [Related]
12. Sexual dysfunction and cardiovascular disease: integrative concepts and strategies.
Billups KL
Am J Cardiol; 2005 Dec; 96(12B):57M-61M. PubMed ID: 16387569
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
Blonde L
Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
[TBL] [Abstract][Full Text] [Related]
14. Current concepts in the evaluation and management of erectile dysfunction.
Ellsworth P; Kirshenbaum EM
Urol Nurs; 2008 Oct; 28(5):357-69. PubMed ID: 18980102
[TBL] [Abstract][Full Text] [Related]
15. A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement--update 2002.
Jackson G; Betteridge J; Dean J; Eardley I; Hall R; Holdright D; Holmes S; Kirby M; Riley A; Sever P
Int J Clin Pract; 2002 Nov; 56(9):663-71. PubMed ID: 12469980
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cardiovascular disease by the early identification of erectile dysfunction.
Jackson G
Int J Impot Res; 2008 Dec; 20 Suppl 2():S9-14. PubMed ID: 19002117
[TBL] [Abstract][Full Text] [Related]
17. A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients.
Schwarz ER; Rastogi S; Rodriguez JJ; Kapur V; Sulemanjee N; Gupta R; Rosanio S
Int J Impot Res; 2005 Dec; 17 Suppl 1():S37-43. PubMed ID: 16391541
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
Gazzaruso C; Solerte SB; Pujia A; Coppola A; Vezzoli M; Salvucci F; Valenti C; Giustina A; Garzaniti A
J Am Coll Cardiol; 2008 May; 51(21):2040-4. PubMed ID: 18498958
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factors determine erectile and arterial function response to sildenafil.
Solomon H; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Jackson G
Am J Hypertens; 2006 Sep; 19(9):915-9. PubMed ID: 16942933
[TBL] [Abstract][Full Text] [Related]
20. Erectile dysfunction: a harbinger or consequence: does its detection lead to a window of curability?
Miner MM
J Androl; 2011; 32(2):125-34. PubMed ID: 20864648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
